References in periodicals archive ?
TM], as a Class IIb Medical Device for the treatment of acute and chronic wounds.
The company is pursuing a multi-faceted strategy to penetrate the chronic wound market with its products, as well as opportunities for the application of AutoloGel(TM) and PRP technology into other markets such as hair transplantation and orthopedics while actively seeking complementary products for the wound care market.
Led by Alex Rickard, assistant professor of biological sciences, the researchers could identify specific types of chronic wound bacteria and to test their ability to produce cell-cell signalling molecules.
A university spokesman said, 'Animal experiments to study chronic wounds can cause substantial pain and suffering.
is a biotechnology company dedicated to the development of natural, biologic therapies for the chronic wound care, dermatology and osteoarthritis markets.
Leveraging its scale and experience, Healogics utilizes an evidence-based systematic approach to chronic wound healing in treating an underserved and growing patient population.
There are approximately 50 million chronic wound cases reported annually, and the incidence of chronic wounds is expected to rise with the steady increase in adult and child obesity.
Biofisica's wound care technology is uniquely positioned to provide chronic wound solutions to the wound care market -- a global market that is estimated in excess of US$12 billion.
Including homecare patients, elders and persons with disabilities, overall estimates of chronic wound care exceed $30 billion annually.
Nitric BioTherapeutics (Nitric Bio) today announced the beginning of a Phase II clinical trial for the treatment of chronic wounds using nitric oxide.
25 billion is spent annually on chronic wound management
The Magnitude and Cost of Chronic Wound Care In the United States, health care cost to treat and manage chronic wounds exceeds $6 billion dollars annually.
This demand is likely to raise the penetration of advanced wound management products in both acute and chronic wound care," says Frost & Sullivan Research Analyst Andrew Wee.
Full browser ?